A two-day training program for the New York State Department of Homeland Security and Emergency Services helps local health officials and first responders convey key messages in a crisis.
A gift totaling $25 million from Irwin M. Jacobs ’54, BEE ’56 and the Jacobs family includes a new $15 million commitment, adding to a $10 million commitment in 2023 that helped establish the center.
A new study emphasizes the importance of considering sex differences in Alzheimer’s research – a step that could ultimately lead to more precise and effective treatments.
A novel combination of surgery and embolization used to treat subdural hematomas, bleeding between the brain and its protective membrane due to trauma, reduces the risk of follow-up surgeries, according to researchers at Weill Cornell Medicine and University at Buffalo.
Cornell researchers have identified a switch that regulates inflammation caused by an immune response, a finding that could one day help to control inflammation-related conditions.
A multidisciplinary team aims to build a more inclusive AI shaped by global cultures and knowledge – one of three projects that make up Cornell’s new GlobalGrand Challenge: The Future.
The findings could lead to new treatments targeting a particular protein to better manage inflammation in patients who don’t respond well to existing therapies.
By repeatedly scanning the brains of a small group of patients for a year and a half, Weill Cornell Medicine researchers have identified a distinct pattern of neuronal interactions that appears to predispose some people to developing depression.
Weill Cornell Medicine is collaborating with colleagues in Tanzania to increase the pipeline of female doctors, researchers and policymakers in health care, and focus attention on women’s health in Tanzania.
A new preclinical model using CRISPR has given Weill Cornell Medicine researchers and their colleagues a deeper insight into how prostate cancer spreads or metastasizes.